These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38472000)

  • 1. Multi-resistant organisms in burn patients: an end or a new beginning.
    Hagiga A; Dheansa B
    Burns; 2024 Jun; 50(5):1045-1052. PubMed ID: 38472000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phage therapy for bacterial infection of burn].
    Peng YZ; Huang GT
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):513-6. PubMed ID: 27647065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Phage Therapy in Burn Wound Infections Management: Advantages and Pitfalls.
    Azevedo MM; Pina-Vaz C; Rodrigues AG
    J Burn Care Res; 2022 Mar; 43(2):336-342. PubMed ID: 34523679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial.
    Jault P; Leclerc T; Jennes S; Pirnay JP; Que YA; Resch G; Rousseau AF; Ravat F; Carsin H; Le Floch R; Schaal JV; Soler C; Fevre C; Arnaud I; Bretaudeau L; Gabard J
    Lancet Infect Dis; 2019 Jan; 19(1):35-45. PubMed ID: 30292481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Knowledge and Perspectives of Phage Therapy for Combating Refractory Wound Infections.
    Wang B; Du L; Dong B; Kou E; Wang L; Zhu Y
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophage therapy reduces
    Molendijk MM; Boekema BKHL; Lattwein KR; Vlig M; Bode LGM; Koopmans MPG; Verbon A; de Graaf M; van Wamel WJB
    Antimicrob Agents Chemother; 2024 Sep; 68(9):e0065024. PubMed ID: 39136463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug-Resistant Organisms: The Silent Plight of Burn Patients.
    Elsheikh R; Makram AM
    J Burn Care Res; 2024 Aug; 45(4):877-886. PubMed ID: 38695094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome loaded phage cocktail: Enhanced therapeutic potential in resolving Klebsiella pneumoniae mediated burn wound infections.
    Chadha P; Katare OP; Chhibber S
    Burns; 2017 Nov; 43(7):1532-1543. PubMed ID: 28502784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Drug-Resistant Organisms in Burn Infections.
    Robben PM; Ayalew MD; Chung KK; Ressner RA
    Surg Infect (Larchmt); 2021 Feb; 22(1):103-112. PubMed ID: 32429798
    [No Abstract]   [Full Text] [Related]  

  • 10. Changing trends in antimicrobial susceptibility pattern of bacterial isolates in a burn unit.
    Singh NP; Rani M; Gupta K; Sagar T; Kaur IR
    Burns; 2017 Aug; 43(5):1083-1087. PubMed ID: 28153582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management and prevention of drug resistant infections in burn patients.
    Vinaik R; Barayan D; Shahrokhi S; Jeschke MG
    Expert Rev Anti Infect Ther; 2019 Aug; 17(8):607-619. PubMed ID: 31353976
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo efficacy of single phage versus phage cocktail in resolving burn wound infection in BALB/c mice.
    Chadha P; Katare OP; Chhibber S
    Microb Pathog; 2016 Oct; 99():68-77. PubMed ID: 27498362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance: use of phage therapy in the management of resistant infections.
    Ikpe F; Williams T; Orok E; Ikpe A
    Mol Biol Rep; 2024 Aug; 51(1):925. PubMed ID: 39167154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are topical antimicrobials effective against bacteria that are highly resistant to systemic antibiotics?
    Neely AN; Gardner J; Durkee P; Warden GD; Greenhalgh DG; Gallagher JJ; Herndon DN; Tompkins RG; Kagan RJ
    J Burn Care Res; 2009; 30(1):19-29. PubMed ID: 19060725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial Infections After Burn Injuries: Impact of Multidrug Resistance.
    Lachiewicz AM; Hauck CG; Weber DJ; Cairns BA; van Duin D
    Clin Infect Dis; 2017 Nov; 65(12):2130-2136. PubMed ID: 29194526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of appropriate empiric gram-negative coverage in a multinational pediatric burn hospital.
    Friedstat JS; Moore ME; Weber JM; Fagan SP; Goverman J
    J Burn Care Res; 2013; 34(1):203-10. PubMed ID: 23292590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burn Wound Microbiology and the Antibiotic Susceptibility Patterns of Bacterial Isolates in Three Burn Units of Abbottabad, Pakistan.
    Hubab M; Maab H; Hayat A; Ur Rehman M
    J Burn Care Res; 2020 Nov; 41(6):1207-1211. PubMed ID: 32403126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging infections in burns.
    Branski LK; Al-Mousawi A; Rivero H; Jeschke MG; Sanford AP; Herndon DN
    Surg Infect (Larchmt); 2009 Oct; 10(5):389-97. PubMed ID: 19810827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the
    Maslova E; Osman S; McCarthy RR
    Microbiology (Reading); 2023 Jun; 169(6):. PubMed ID: 37350463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiology of burn wound infections.
    Polavarapu N; Ogilvie MP; Panthaki ZJ
    J Craniofac Surg; 2008 Jul; 19(4):899-902. PubMed ID: 18650708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.